drugset / Trial / NCT02665637
Study Comparing Pharmacokinetics, Safety and Immunogenicity of CT-P6 and US-licensed Herceptin
RandomizedParallel-groupDouble-blind
Summary
This is a double-blind, two-arm, parallel-group, single-dose study.
Timeline
- Start
- 2015-12
- Primary completion
- 2016-04
- Completion
- 2016-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Trastuzumab | Monoclonal antibody | — | Intravenous |
Indications
No indication recorded.